Journal of Pharmacology and Experimental Therapeutics: 279 (1)

October 01, 1996; Volume 279,Issue 1

Articles

You have access
ERRATUM
Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 442;
You have access
ERRATUM
Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 442;

You have access
Effects of gonadal steroids on vascular function.
S P Duckles, D N Krause and V M Miller

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 1-3;
You have access
In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.
R B Kim, H Yamazaki, K Chiba, D O'Shea, M Mimura, F P Guengerich, T Ishizaki, T Shimada and G R Wilkinson

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 4-11;
You have access
Evaluation of sex- and strain-dependency of cocaine-induced immunosuppression in B6C3F1 and DBA/2 mice.
R A Matulka, S D Jordan, E D Stanulis and M P Holsapple

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 12-17;
You have access
Melatonin modulation of presynaptic nicotinic acetylcholine receptors in the rat vas deferens.
R P Markus, W M Zago and R C Carneiro

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 18-22;
You have access
Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
G Zernig, T Burke, J W Lewis and J H Woods

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 23-31;
You have access
Dilazep and its derivative, K-7259, attenuate mechanical derangement induced by palmitoyl-L-carnitine in the isolated, perfused rat heart.
A Hara, H Hashizume and Y Abiko

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 32-38;
You have access
Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
L F Tseng and K A Collins

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 39-46;
You have access
Restoration of ischemic contractile failure of indo-1-loaded guinea pig heart by a calcium sensitizer, MCI-154.
Y Abe, K Sekioka, R Ishisu, K Onishi, Y Ueda and T Nakano

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 47-55;
You have access
Binding of the volatile anesthetic halothane to the hydrophobic core of a tetra-alpha-helix-bundle protein.
J S Johansson, F Rabanal and P L Dutton

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 56-61;
You have access
[3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
B M Baron, B W Siegel, B L Harrison, R S Gross, C Hawes and P Towers

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 62-68;
You have access
Inhalation exposure to volatilized opioids produces antinociception in mice.
A H Lichtman, Y Meng and B R Martin

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 69-76;
You have access
Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
D Wu and W M Pardridge

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 77-83;
You have access
Endogenous tumor necrosis factor enhances topoisomerase II inhibitors activity in human ovarian cancer cell lines.
D Debernardis, S Stanzione, C Ottoboni, L Clerico, T Mancuso, S Parodi and P Russo

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 84-90;
You have access
Nitric oxide generation by renal proximal tubules: role of nitric oxide in the cytotoxicity of lipid A.
L A Traylor, J W Proksch, V C Beanum and P R Mayeux

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 91-96;
You have access
Effects of a phorbol ester and isoquinoline sulfonamides on rabbit parietal cell function.
J Nandi, M C Bosche and R A Levine

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 97-105;
You have access
Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain.
T Kobayashi, K Matsuno, K Nakata and S Mita

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 106-113;
You have access
The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
S J Vyas, Z Mi and E K Jackson

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 114-119;
You have access
Effects of levosimendan on myocardial contractility and oxygen consumption.
K Todaka, J Wang, G H Yi, R Stennett, M Knecht, M Packer and D Burkhoff

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 120-127;
You have access
Gangliosides reduce the development of ethanol dependence without affecting ethanol tolerance.
L D Snell, G Szabó, B Tabakoff and P L Hoffman

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 128-136;
You have access
Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching.
D F Woodward, A L Nieves and M H Friedlaender

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 137-142;
You have access
Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons.
M Marchioro, K L Swanson, Y Aracava and E X Albuquerque

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 143-153;
You have access
Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
D R Lynch and M J Gallagher

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 154-161;
You have access
Pharmacological advantages of conjugation of Cu, Zn-superoxide dismutase with succinylated keratin fragment: improvement of biological properties and resistance to oxidative damage.
J Noda, M Otagiri, T Akaike and H Maeda

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 162-171;
You have access
Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone.
G Patrini, P Massi, G Ricevuti, A Mazzone, G Fossati, I Mazzucchelli, E Gori and D Parolaro

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 172-176;
You have access
Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
T Suzuki, M Tsuji, T Mori, M Misawa, T Endoh and H Nagase

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 177-185;
You have access
Effects of the androgenic/anabolic steroid stanozolol on GABAA receptor function: GABA-stimulated 36Cl- influx and [35S] TBPS binding.
A E Masonis and M P McCarthy

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 186-193;
You have access
Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons.
M D Miñana, C Hermenegildo, M Llsansola, C Montoliu, S Grisolía and V Felipo

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 194-199;
You have access
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
A E Fleckenstein, S Pögün, F I Carroll and M J Kuhar

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 200-206;
You have access
Platelet-activating factor (PAF) stimulates giant migrating contractions during ileal inflammation.
P Jouët and S K Sarna

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 207-213;
You have access
Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay.
S Wilson, J K Chambers, J E Park, A Ladurner, D W Cronk, C G Chapman, H Kallender, M J Browne, G J Murphy and P W Young

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 214-221;
You have access
Species differences in the disposition and metabolism of nalidixic acid.
A A Nomeir, P Markham, L T Burka, R J Griffin and B I Ghanayem

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 222-230;
You have access
Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload.
L Carlsson, L Drews and G Duker

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 231-239;
You have access
Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition.
O Kaminuma, A Mori, M Suko, H Kikkawa, K Ikezawa and H Okudaira

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 240-246;
You have access
Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors.
M R Bergman and B J Holycross

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 247-254;
You have access
Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet.
L Grélot, H Le Stunff, S Milano, P R Blower and D Romain

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 255-261;
You have access
Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
M Senchyna and D J Crankshaw

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 262-270;
You have access
Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine.
C Ito, K Onodera, E Sakurai, M Sato and T Watanabe

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 271-276;
You have access
Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.
S E Gartside, R McQuade and T Sharp

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 277-283;
You have access
Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake.
K Sawai, R I Mahato, Y Oka, Y Takakura and M Hashida

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 284-290;
You have access
The systemic and cerebral kinetics of thiopental in sheep: enantiomeric analysis.
L E Mather, R N Upton, J L Huang, G L Ludbrook, E Gray and C Grant

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 291-297;
You have access
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
M Sato, H U Bryant, P Iversen, J Helterbrand, F Smietana, K Bemis, R Higgs, C H Turner, I Owan, Y Takano and D B Burr

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 298-305;
You have access
Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
P Vergara, Z Woskowska, S Cipris, J E Fox-Threlkeld and E E Daniel

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 306-316;
You have access
Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
B E Heisler and G R Ferrier

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 317-324;
You have access
Evaluation of cerebral pharmacokinetics of the novel antidepressant drug, BMS-181101, by positron emission tomography.
B T Christian, E Livni, J W Babich, N M Alpert, D D Dischino, E Ruediger, D E Salazar, N F Ford and A J Fischman

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 325-331;
You have access
Hypothermia and metabolic stress: narrowing the cellular site of early neuroprotection.
G D Zeevalk and W J Nicklas

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 332-339;
You have access
Soluble cytokine receptors as carrier proteins: effects of soluble interleukin-4 receptors on the pharmacokinetics of murine interleukin-4.
Y Ma, H E Hurst and R Fernandez-Botran

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 340-350;
You have access
Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
Y Zhou, R Spangler, K S LaForge, C E Maggos, A Ho and M J Kreek

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 351-358;
You have access
Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria.
B G Devi and A W Chan

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 359-366;
You have access
Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells.
M A Varney, C Jachec, C Deal, S D Hess, L P Daggett, R Skvoretz, M Urcan, J H Morrison, T Moran, E C Johnson and G Veliçelebi

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 367-378;
You have access
Neural stimulation of Egr-1 messenger RNA expression in rat adrenal gland: possible relation to phenylethanolamine N-methyltransferase gene regulation.
K Morita, R A Bell, B J Siddall and D L Wong

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 379-385;
You have access
Ontogeny and hormonal basis of female-dominant rat hepatic sulfotransferases.
L Liu and C D Klaassen

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 386-391;
You have access
Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference.
D A Baker, T V Khroyan, L E O'Dell, R A Fuchs and J L Neisewander

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 392-401;
You have access
Inhibitory mechanism of CO2 inhalation on slowly adapting pulmonary stretch receptors in the anesthetized rabbit.
S Matsumoto, H Okamura, K Suzuki, N Sugai and T Shimizu

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 402-409;
You have access
Glutamate ameliorates experimental vincristine neuropathy.
F M Boyle, H R Wheeler and G M Shenfield

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 410-415;
You have access
In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.
P M Lacal, S D'Atri, L Orlando, E Bonmassar and G Graziani

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 416-422;
You have access
Radioligand binding, autoradiographic and functional studies demonstrate tachykinin NK-2 receptors in dog urinary bladder.
C J Mussap, C Stamatakos and E Burcher

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 423-434;
You have access
Lead (Pb+2) promotes apoptosis in newborn rat cerebellar neurons: pathological implications.
A Oberto, N Marks, H L Evans and A Guidotti

Journal of Pharmacology and Experimental Therapeutics October 1996, 279 (1) 435-442;

Main menu

User menu

Search

Table of Contents

Articles

In this issue

Jump to

Navigate

More Information

ASPET's Other Journals